Bedfont Scientific named Technology Business of the Year
Medical device manufacturer Bedfont Scientific has been recognised as Technology Business of the Year at the Kent Excellence in Business Awards (KEiBA) 2018.
Medical device manufacturer Bedfont Scientific has been recognised as Technology Business of the Year at the Kent Excellence in Business Awards (KEiBA) 2018.
BPR Medical has welcomed the US Veterans Health Administration (VA) decision to mandate the use of thermal fuses – also known as firebreaks – in all its home oxygen (O2) patient installations.
Deutsche Intensivpflege Holding (DIH), the health service provider, will take over Linde REMEO Deutschland GmbH (REMEO).
Marken, a wholly owned subsidiary of UPS dedicated to the pharmaceutical and life sciences industries, will be expanding Its cryogenic service locations to facilitate global cell and gene therapy trials.
NeuroproteXeon have completed a distribution agreement with Linde AG for XENEXTM (xenon by inhalation) for Post Cardiac Arrest Syndrome (PCAS) for the European Union plus United Kingdom, Switzerland, Norway and Iceland.
Since 1938, the US Food and Drug Administration (FDA) established regulations for drug manufacturers. Medical gases are considered prescription drugs and are covered by these regulations. The regulations (21 CFR Part 211) have been revised...
From the family garage to a global manufacturing facility, SuperFlash is a homegrown Ohio company with an international audience. Owner and CEO David Marquard, who has deep experience in the gases industry, founded SuperFlash in...
African Oxygen Limited (Afrox) has been awarded the South African State Healthcare Contract to supply medical gases to Government hospitals, National Treasury has confirmed.
GCE Healthcare has announced the launch of a secure online platform that will enable home oxygen (O2) providers to remotely monitor GCE’s Zen-O™ portable oxygen concentrator (POC).
Bedfont Scientific Ltd. has made a 510(k) submission for US FDA clearance of their ToxCO® monitor used by emergency services to mass screen for carbon monoxide (CO) poisoning.